78 results on '"T T, Wang"'
Search Results
2. [Genotype and phenotype of WWOX gene related developmental and epileptic encephalopathy].
- Author
-
Wang T, Cheng MM, Liu WW, Tan QZ, Liu CH, Yang Y, Yang XL, and Zhang YH
- Subjects
- Humans, Male, Female, Infant, Spasms, Infantile genetics, Epilepsy genetics, Epilepsy diagnosis, Infant, Newborn, Magnetic Resonance Imaging, Seizures genetics, Microcephaly genetics, Developmental Disabilities genetics, Child, Preschool, Tumor Suppressor Proteins genetics, WW Domain-Containing Oxidoreductase genetics, Phenotype, Genotype, Electroencephalography, Mutation
- Abstract
Objective: To summarize the genotype and clinical phenotype of children with WWOX gene related developmental and epileptic encephalopathy (DEE). Methods: Case series studies. The clinical data of 12 children with WWOX gene related DEE who were admitted to the Neurological Department of Children's Medical Center, Peking University First Hospital from June 2019 to December 2023 were analyzed. The children's characteristics of gene variation, clinical phenotype, auxiliary examination results, treatment and prognosis were analyzed. Results: Among 12 children with WWOX gene related DEE, there were 7 boys and 5 girls, the age of seizure onset ranged from 10 days to 6 months (median 1.8 months). Multiple seizure types were observed, including focal seizures in 10 cases, epileptic spasms in 9 cases, tonic seizures in 4 cases, myoclonic seizures in 1 case. Among 12 cases, 9 cases had multiple seizure types. All 12 cases showed microcephaly and global developmental delay. Video electroencephalography showed slowed background activity in 6 cases, hyperarrhythmia in 6 cases, multifocal discharges in 6 cases, and focal discharges in 1 case. Epileptic spasms were detected in 8 cases, tonic seizures in 4 cases and myoclonic seizures in 1 case. Brain magnetic resonance imaging showed bilateral frontotemporal subarachnoid space widening in 5 cases, deep sulci in 3 cases, bilateral ventricular enlargement in 2 cases, callosal hypoplasia in 5 cases, and delayed white matter myelination in 3 cases. The phenotypes of 12 cases were consistent with the diagnosis of DEE, and 8 of them were diagnosed with infantile epileptic spasm syndrome. All the WWOX gene variants in 12 cases were complex heterozygous variants, including 20 variants, 11 variants and 1 large intragenic WWOX gene deletion (p.Ala149Thr, p.Arg156Ser, p.R167Tfs*8, p.Leu186Val, c.605+5G>A, p.Trp218*, p.His263Arg, p.Leu275fs*19*1, p.N285Kfs*10, p.Ser304Tyr, p.Met326Arg, loss1 exon2-8) had not been reported previously. The age of last follow-up ranged from 11 months to 5 years and 3 months. During the follow-up, 1 case died at the age of 1 year and 10 months, 2 cases were seizure-free, and 9 cases still had seizures after multiple anti-seizure medications. Conclusions: The seizure onset age of children with WWOX gene related DEE is usually less than 6 months, and some of them in neonate. The common seizure types include focal seizures and epileptic spasms. Children usually have microcephaly and global developmental delay. WWOX gene related DEE usually has drug refractory epilepsy.
- Published
- 2024
- Full Text
- View/download PDF
3. [Bronchoscopic intervention therapy for pulmonary mucormycosis with main bronchial occlusion: a case report].
- Author
-
Wu XX, Wang J, Jin YK, Lin L, Qiu XJ, Zhang J, and Wang T
- Subjects
- Humans, Male, Middle Aged, Antifungal Agents therapeutic use, Mucormycosis therapy, Mucormycosis diagnosis, Bronchoscopy methods, Lung Diseases, Fungal therapy
- Abstract
Pulmonary mucormycosis is one of the most common types of mucormycosis. Tracheobronchial pulmonary mucormycosis primarily affects the tracheobronchial tree, causing lesions that can invade the airway mucosa and muscular layer, damaging the cartilage. It is characterised by acute onset, rapid progression, and high mortality rate, making clinical treatment challenging. This article reports the diagnosis and treatment of a patient with pulmonary mucormycosis complicated by left main bronchus occlusion. In addition to systemic treatment, which consisted mainly of an intravenous injection of amphotericin B combined with an oral suspension of posaconazole, the patient underwent multiple bronchoscopic interventions, including local infusion of amphotericin B under endoscopy, balloon dilation and silicone stent placement. After four months of comprehensive treatment, the therapeutic effect was satisfactory. This report demonstrates that bronchoscopic intervention therapy plays an important role in the comprehensive treatment of pulmonary mucormycosis, especially in preventing death from the progression to obstructive pneumonia.
- Published
- 2024
- Full Text
- View/download PDF
4. [Clinical significance of IL-18 and IL-18-binding protein in bone marrow of patients with myelodysplastic syndrome].
- Author
-
Wang T, Ran NY, Chen QL, Liu DL, Zang MT, Li NB, He X, Guan J, Fu R, and Shao ZH
- Subjects
- Humans, CD8-Positive T-Lymphocytes metabolism, Male, Female, Killer Cells, Natural metabolism, Middle Aged, Clinical Relevance, Myelodysplastic Syndromes metabolism, Interleukin-18 metabolism, Bone Marrow metabolism, Intercellular Signaling Peptides and Proteins metabolism
- Abstract
Objective: To analyze the level and clinical significance of IL-18 and IL-18-binding protein (BP) in the bone marrow of patients with myelodysplastic syndrome (MDS) . Methods: A total of 43 newly diagnosed patients with MDS who were admitted to the Department of Hematology, Tianjin Medical University General Hospital, from July 2020 to February 2021 were randomly selected. The control group consisted of 14 patients with acute myeloid leukemia (AML) and 25 patients with iron-deficiency anemia (IDA). The levels of IL-18 and IL-18 BP in the bone marrow supernatant were measured, and their correlations with MDS severity, as well as the functionality of CD8(+) T cells and natural killer cells, was analyzed. Results: The levels of IL-18, IL-18 BP, and free IL-18 (fIL-18) in the bone marrow supernatant of patients with MDS were higher than in the IDA group. The level of fIL-18 was linearly and negatively correlated with the MDS-International Prognostic Scoring System (IPSS) score. IL-18 receptor (IL-18Rα) expression on CD8(+) T cells in the MDS group was lower than in the IDA group, and the levels of fIL-18 and IL-18Rα were positively correlated with CD8(+) T-cell function in the MDS group. Conclusion: IL-18 BP antagonizes IL-18, leading to a decrease in fIL-18 in the bone marrow microenvironment of patients with MDS, affecting CD8(+) T-cell function, which is closely related to MDS severity; therefore, it may become a new target for MDS treatment.
- Published
- 2024
- Full Text
- View/download PDF
5. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
- Author
-
Yin JJ, Qian L, Bai JF, Feng R, Li JT, Wang T, Zhang CL, and Liu H
- Subjects
- Humans, Aged, Male, Female, Middle Aged, Retrospective Studies, Prognosis, Aged, 80 and over, Survival Analysis, Adult, Survival Rate, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Follicular diagnosis, Lymphoma, Follicular mortality, Lymphoma, Follicular therapy, Geriatric Assessment methods
- Abstract
Objective: To retrospectively analyze the clinical characteristics and prognosis of 85 newly diagnosed patients with follicular lymphoma (FL), as well as the prognostic value of comprehensive geriatric assessment (CGA) in patients with FL aged ≥ 60 years old. Methods: The clinical data and prognosis of 85 newly diagnosed FL patients admitted from August 2011 to June 2022 were collected. The clinical features, laboratory indicators, therapeutic efficacy, survival and prognostic factors of patients were statistically analyzed, and the prognosis of patients was stratified using various geriatric assessment tools. Results: ① The patients with FL were mostly middle-aged and older, with a median age of 59 (20-87) years, including 41 patients (48.2%) aged ≥60 years. The ratio of male to female was 1∶1.36. Overall, 77.6% of the patients were diagnosed with Ann Arbor stage Ⅲ-Ⅳ, and 17 cases (20.0%) were accompanied by B symptoms. Bone marrow involvement was the most common (34.1%). ②Overall, 71 patients received immunochemotherapy. The overall response rate was 86.6%, and the complete recovery rate was 47.1% of 68 evaluated patients. Disease progression or relapse in the first 2 years was observed in 23.9% of the patient. Overall, 14.1% of the patients died during follow-up. ③Of the 56 patients receiving R-CHOP-like therapies, the 3-year and 5-year progression-free survival (PFS) rates were 85.2% and 72.8%, respectively, and the 3-year and 5-year overall survival (OS) rates were 95.9% and 88.8%, respectively. The univariate analysis showed that age ≥60 years old ( HR =3.430, 95% CI 1.256-9.371, P =0.016), B symptoms ( HR =5.030, 95% CI 1.903-13.294, P =0.016), Prognostic Nutritional Index (PNI) <45.25 ( HR =3.478, 95% CI 1.299-9.310, P =0.013), Follicular Lymphoma International Prognostic Index (FLIPI) high-risk ( HR =2.918, 95% CI 1.074-7.928, P =0.036), and PRIMA-prognostic index (PRIMA-PI) high-risk ( HR =2.745, 95% CI 1.057-7.129, P =0.038) significantly predicted PFS. Moreover, age ≥60 years old and B symptoms were independent risk factors for PFS. Progression of disease within 24 months (POD24) significantly predicted OS in the univariate analysis. Conclusions: FL is more common among middle-aged and older women. Age, B symptoms, PNI score, FLIPI high-risk, PRIMA-PI high-risk, and POD24 influenced PFS and OS. The CGA can be used for treatment selection and risk prognostication in older patients with FL.
- Published
- 2024
- Full Text
- View/download PDF
6. [Efficacy and safety of eltrombopag in the treatment of primary immune thrombocytopenia: real-world data from a single medical center].
- Author
-
Dong XF, Li YL, Li NB, Lin WN, Wang T, Wang HQ, Li LJ, Qu W, Xing LM, Liu H, Wu YH, Wang GJ, Song J, Guan J, Wang XM, Shao ZH, and Fu R
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Adult, Aged, Adolescent, Aged, 80 and over, Treatment Outcome, Child, Young Adult, Hemorrhage, Purpura, Thrombocytopenic, Idiopathic drug therapy, Pyrazoles administration & dosage, Pyrazoles therapeutic use, Benzoates administration & dosage, Benzoates therapeutic use, Benzoates adverse effects, Hydrazines therapeutic use, Hydrazines administration & dosage
- Abstract
Objective: This study aimed at investigating the efficacy and safety of eltrombopag in the treatment of adult primary immune thrombocytopenia (ITP) and evaluated the factors influencing its efficacy and side effects. Methods: A total of 198 patients with adult ITP who were admitted to Tianjin Medical University General Hospital between January 2018 and March 2022 were retrospectively analyzed. The efficacy of each starting dose of eltrombopag was evaluated, and adverse events were analyzed. The factors influencing efficacy were investigated, including sex, age, adult ITP type, platelet antibodies, and combined drug treatments. Results: Of the 198 patients, 70 males and 128 females with a median age of 45 years (18-88 years) were included; 130 (65.7%) had newly diagnosed adult ITP, 25 (12.6%) had persistent adult ITP, and 43 (21.7%) had chronic adult ITP. The bleeding event scores at baseline were assessed; 84.3% had scores of<4 and 15.7% had scores of ≥4. The eltrombopag response rate (initial response) at 6 weeks was 78.8% (complete response [CR]: 49.0%; CR1: 14.6%; CR2: 15.2%). The median response time to eltrombopag was 7 (7, 14) days. The initial response rates to 25, 50, and 75 mg eltrombopag were 74.1%, 85.9%, and 60.0%, respectively ( P =0.031). The initial response rate to the 50 mg dose was significantly higher than that of the 25-mg and 75-mg doses. Two patients received 100 mg as the starting dose, and their initial response was 0. Regarding dose adjustment, 70.7% of the patients remained on the starting dose, 8.6% underwent dose adjustment to 50 mg, and 6.1% underwent dose adjustment to 75 mg. Another two patients underwent dose adjustment to 100 mg. After dose adjustment, the persistent response rates were 83.6%, 85.3%, and 85.7% for the 25-, 50-, and 75-mg doses, respectively, with no significant difference. After dose adjustment, the sustained efficacy rate for the 100-mg dose (4 patients) was 100.0%. After 6 weeks of treatment with eltrombopag, the overall bleeding score of patients with ITP decreased. The number of patients with a score of ≥4 decreased to 0, the number of patients with a score of<4 decreased, and there was no significant change in the number of patients with a score of 1-2. The most common adverse event associated with eltrombopag was impaired liver function (7.7%). No thrombosis events or other adverse events were observed. ITP type and number of megakaryocytes significantly affected the initial response to eltrombopag. The initial response rates to eltrombopag for newly diagnosed adult ITP, persistent adult ITP, and chronic adult ITP were 85.3%, 56.0%, and 76.2%, respectively ( P =0.003). For megakaryocytes, the initial response rates were 61.8%, 87.1%, and 84.3% ( P =0.009) for the decreased, normal, and increased megakaryocyte groups, respectively. Conclusion: Eltrombopag, as a second-line or higher treatment for adult ITP, has a rapid onset of action and good safety. The initial response rate is significantly higher with a dose of 50 mg than with a dose of 25 mg. Patients with newly diagnosed ITP and those with normal or increased megakaryocyte numbers have a higher initial response rate to eltrombopag.
- Published
- 2024
- Full Text
- View/download PDF
7. [Advances in the role of infection in the development of benign tracheal stenosis].
- Author
-
Kong YY, Wang T, and Zhang J
- Subjects
- Humans, Tracheal Stenosis etiology, Infections complications
- Abstract
Benign tracheal stenosis (BTS) is a refractory disease with a complex pathogenesis and limited therapeutic drug effects. The management of benign tracheal stenosis remains a major challenge for the interventional physiologist. In recent years, the role of infection in the occurrence and development of tracheal stenosis has attracted some attention, but there is still some controversy. A clear understanding of the relationship between infection and tracheal stenosis is essential to elucidate the pathogenic mechanism of BTS, and then to improve early prevention and management of BTS. This article reviewed the research progress on BTS associated with infection to explore new effective interventions that can reduce the BTS.
- Published
- 2024
- Full Text
- View/download PDF
8. [Different methods in predicting mortality of pediatric intensive care units sepsis in Southwest China].
- Author
-
Liu R, Yu ZC, Xiao CX, Xiao SF, He J, Shi Y, Hua YY, Zhou JM, Zhang GY, Wang T, Jiang JY, Xiong DX, Chen Y, Xu HB, Yun H, Sun H, Pan TT, Wang R, Zhu SM, Huang D, Liu YJ, Hu YH, Ren XR, Shi MF, Song SZ, Luo JM, Liu J, Zhang J, and Xu F
- Subjects
- Humans, Child, Male, Female, Prospective Studies, Retrospective Studies, Systemic Inflammatory Response Syndrome diagnosis, Intensive Care Units, Pediatric, Prognosis, China epidemiology, Critical Illness, ROC Curve, Intensive Care Units, Sepsis diagnosis
- Abstract
Objective: To investigate the value of systemic inflammatory response syndrome (SIRS), pediatric sequential organ failure assessment (pSOFA) and pediatric critical illness score (PCIS) in predicting mortality of pediatric sepsis in pediatric intensive care units (PICU) from Southwest China. Methods: This was a prospective multicenter observational study. A total of 447 children with sepsis admitted to 12 PICU in Southwest China from April 2022 to March 2023 were enrolled. Based on the prognosis, the patients were divided into survival group and non-survival group. The physiological parameters of SIRS, pSOFA and PCIS were recorded and scored within 24 h after PICU admission. The general clinical data and some laboratory results were recorded. The area under the curve (AUC) of the receiver operating characteristic curve was used to compare the predictive value of SIRS, pSOFA and PCIS in mortality of pediatric sepsis. Results: Amongst 447 children with sepsis, 260 patients were male and 187 patients were female, aged 2.5 (0.8, 7.0) years, 405 patients were in the survival group and 42 patients were in the non-survival group. 418 patients (93.5%) met the criteria of SIRS, and 440 patients (98.4%) met the criteria of pSOFA≥2. There was no significant difference in the number of items meeting the SIRS criteria between the survival group and the non-survival group (3(2, 4) vs. 3(3, 4) points, Z= 1.30, P= 0.192). The pSOFA score of the non-survival group was significantly higher than that of the survival group (9(6, 12) vs . 4(3, 7) points, Z= 6.56, P< 0.001), and the PCIS score was significantly lower than that of the survival group (72(68, 81) vs . 82(76, 88) points, Z= 5.90, P< 0.001). The predictive value of pSOFA (AUC=0.82) and PCIS (AUC=0.78) for sepsis mortality was significantly higher than that of SIRS (AUC=0.56) ( Z= 6.59, 4.23, both P< 0.001). There was no significant difference between pSOFA and PCIS ( Z= 1.35, P= 0.176). Platelet count, procalcitonin, lactic acid, albumin, creatinine, total bilirubin, activated partial thromboplastin time, prothrombin time and international normalized ratio were all able to predict mortality of sepsis to a certain degree (AUC=0.64, 0.68, 0.80, 0.64, 0.68, 0.60, 0.77, 0.75, 0.76, all P< 0.05). Conclusion: Compared with SIRS, both pSOFA and PCIS had better predictive value in the mortality of pediatric sepsis in PICU.
- Published
- 2024
- Full Text
- View/download PDF
9. [Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].
- Author
-
Ding SX, Zhao YH, Wang T, Guan J, Xing LM, Liu H, Wang GJ, Wang XM, Wu YH, Qu W, Song J, Wang HQ, Li LJ, Shao ZH, and Fu R
- Subjects
- Humans, Ferric Oxide, Saccharated therapeutic use, Infusions, Intravenous, Retrospective Studies, Ferric Compounds therapeutic use, Ferric Compounds adverse effects, Iron, Hemoglobins analysis, Hemoglobins therapeutic use, Anemia, Iron-Deficiency drug therapy, Anemia, Iron-Deficiency chemically induced, Disaccharides
- Abstract
Objective: To investigate the clinical efficacy and safety of ferric derisomaltose injection versus iron sucrose injection in the treatment of iron deficiency anemia (IDA) . Methods: A total of 120 patients with iron deficiency anemia admitted from June 2021 to March 2023 were given intravenous iron supplementation with ferric derisomaltose to assess the efficacy and safety of hemoglobin (HGB) elevation before and after treatment. Simultaneously, the clinical effects of iron supplementation with iron sucrose were compared to those of inpatient patients during the same period. Results: Baseline values were comparable in both groups. Within 12 weeks of treatment, the elevated HGB level in the ferric derisomaltose group was higher than that of the iron sucrose group, with a statistical difference at all time points, and the proportion of HGB increased over 20 g/L in the patients treated for 4 weeks was higher (98.7%, 75.9% ). During the treatment with ferric derisomaltose and iron sucrose, the proportion of mild adverse reactions in the ferric derisomaltose group was slightly lower than that of the iron sucrose group, and neither group experienced any serious adverse reactions. The patients responded well to the infusion treatment, with no reports of pain or pigmentation at the injection site. Conclusion: The treatment of IDA patients with ferric derisomaltose has a satisfactory curative effect, with the advantages of rapidity, accuracy, and safety. Therefore, it is worthy of widespread clinical use.
- Published
- 2024
- Full Text
- View/download PDF
10. [Acute lymphoblastic leukemia with inv(11)(q21q23.3)/KMT2A::MAML2 fusion gene progressed to acute myeloid leukemia: a case report].
- Author
-
Zhang Y, Ni JB, Zhang QJ, Hui S, Wang CF, and Wang T
- Subjects
- Humans, Trans-Activators genetics, Transcription Factors genetics, Leukemia, Myeloid, Acute genetics, Myeloid-Lymphoid Leukemia Protein genetics, Oncogene Proteins, Fusion genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma genetics
- Published
- 2024
- Full Text
- View/download PDF
11. [Swyer syndrome with gonadal non-dysgerminoma malignant germ cell tumors: a report of 15 cases in a national medical center].
- Author
-
Liang H, Li SJ, Yang JX, Wu M, Cao DY, Wang JH, Wang T, and Zhang XY
- Subjects
- Female, Humans, Retrospective Studies, Gonadal Dysgenesis, 46,XY diagnosis, Gonadal Dysgenesis, 46,XY pathology, Gonadal Dysgenesis, 46,XY surgery, Gonadoblastoma pathology, Gonadoblastoma surgery, Neoplasms, Germ Cell and Embryonal surgery, Ovarian Neoplasms diagnosis, Ovarian Neoplasms surgery, Ovarian Neoplasms pathology
- Abstract
Objective: To evaluate the incidence, treatment, and survival outcomes of Swyer syndrome with gonadal non-dysgerminoma malignant germ cell tumor (MGCT-NDG). Methods: A retrospective study was performed on Swyer syndrome patients with MGCT-NDG between January 2011 and December 2022 in Peking Union Medical College Hospital to investigate their characteristics and outcomes. Results: A total of 15 patients (4.9%, 15/307) with Swyer syndrome were identified in 307 MGCT-NDG patients. The average age at diagnosis of MGCT-NDG and Swyer syndrome were (16.8±6.7) and (16.7±6.6) years, respectively. Six cases were preoperatively diagnosed as Swyer syndrome, of which 4 cases received bilateral gonadectomy with or without hysterectomy, while the other 2 cases underwent removal of gonadal tumor and unilateral gonadectomy with hysterectomy, respectively. Of the 9 patients postoperatively diagnosed as Swyer syndrome, unilateral gonadectomy, removal of gonadal tumor, and unilateral gonadectomy with hysterectomy were performed in 6 patients, 2 patients, and 1 patient, respectively. Mixed malignant germ cell tumor (MGCT;10 cases), yolk sac tumor (4 cases), and immature teratoma (1 case) were the pathological subtypes, in the descending order. There were International Federation of Gynecology and Obstetrics (FIGO) stage Ⅰ in 6 cases, stage Ⅱ in 3 cases, stage Ⅲ in 5 cases, and stage Ⅳ in 1 case, respectively. Eleven patients received reoperation for residual gonadectomy after a average delay of (7.9±6.2) months, including 8 MGCT-NDG patients and 1 gonadoblastoma patient, no tumor involved was seen in the remaining gonads in the other 2 cases. Ten patients experienced at least one recurrence, with a median event free survival of 9 months (5, 30 months), of which 2 patients received surgery only at the time of initial treatment. All patients with recurrence received surgery and combined with postoperative chemotherapy. After a median follow-up of 25 months (15, 42 months), 10 patients were disease-free, 3 patients died of the tumor, 1 died of side effects of leukemia chemotherapy, and 1 survived with disease. Conclusion: The incidence rate of Swyer syndrome in patients with MGCT-NDG is about 4.9%; timely diagnosis and bilateral gonadectomy should be emphasized to reduce the risk of reoperation and second carcinogenesis in this population.
- Published
- 2024
- Full Text
- View/download PDF
12. [Clinical application effect of pedunculated rectus abdominis muscle combined with bilateral ureters for repairing refractory bladder-vaginal stump fistula through external vesical drainage].
- Author
-
Wang GC, Wang GY, Zhao J, Guo LL, Tian KK, Wang T, Gao CQ, Li LJ, Liu YJ, Zhang GQ, Wang YC, Ding LL, Zhang Z, Wang C, and Qi ZC
- Subjects
- Female, Humans, Urinary Bladder surgery, Rectus Abdominis, Drainage, Ureter surgery, Fistula
- Abstract
Objective: To investigate the efficacy and safety of pedunculated rectus abdominis combined with bilateral ureteral extravestheter drainage in the treatment of refractory bladder-vaginal stump fistula. Methods: The clinical data of 8 cases of the refractory bladder-vaginal stump fistula were admitted to the Second Hospital of Hebei Medical University and Henan Cancer Hospital and underwent the clinical treatment of bladder-vaginal stump from December 2019 to December 2022 were collected. The reason of refractory bladder-vaginal stump fistula was analyzed, the operation manner of pedunculated rectus abdominis combined with peduncle and bilateral ureter for the treatment of bladder-vaginal stump through extrabladder drainage was explored. The operation time, bleeding volume and clinical effect were record. Results: The median operation time of 8 patients was 150 minutes(120~180 min), and the median blood loss was 400 ml(200~600 ml). During the perioperative period, there were 2 cases of incision infection, delayed healing by debridement and dressing, 2 cases of incision rupture and suture wound healing after reoperation, and 2 cases of urinary tract infection were cured by anti-infection. When followed up for 6 months, 8 cases of vesicovaginal stump fistula were cured. Conclusion: Bilateral ureteral external drainage of the rectus abdominis muscle, has a practical effect in the treatment of refractory bladder-vaginal stump fistula, which can be one of the clinical repairing treatment.
- Published
- 2023
- Full Text
- View/download PDF
13. [Safety and effectiveness of interventional bronchoscopy under general anesthesia in the elderly patients with central airway stenosis: a retrospective study].
- Author
-
Jia XH, Wang J, Qiu XJ, Wang T, and Zhang J
- Subjects
- Aged, Humans, Bronchoscopy adverse effects, Bronchoscopy methods, Retrospective Studies, Constriction, Pathologic, Anesthesia, General methods, Stents, Laryngeal Masks, Airway Obstruction surgery
- Abstract
We retrospectively reviewed the clinical data of patients aged 65 years and older with central airway stenosis who underwent therapeutic bronchoscopy under general anesthesia in Beijing Tiantan Hospital from January 2012 to September 2022. A total of 167 patients were included in the study. One or more comorbidities were present in 151 patients. The number of operation procedure was 230 times. Laryngeal mask ventilation under general anesthesia and electrotomy was the most common method of airway management and operation. The incidence of major complications was 5.2%. One patient with granular cell tumor died of major bleeding during stent removal. The primary malignant lesion, number of comorbidities, electrolyte disturbances and rigid bronchoscopy were risk factors for major complications, and the difference was statistically significant. The overall response rate was 99.4%. The airway stenosis grade, dyspnea score and KPS value were improved, and the differences were statistically significant. Interventional bronchoscopy under general anesthesia appeared to be safe and effective in patients aged 65 years and older with central airway stenosis. Age should not be a contraindication to interventional bronchoscopy.
- Published
- 2023
- Full Text
- View/download PDF
14. [A multicenter clinical trial of collar-button type keratoprosthesis implantation for the treatment of corneal blindness in high-risk transplantation].
- Author
-
Zhang T, Wang LL, Gu JJ, Xu JJ, Chen W, Huang YF, Hong JX, Wang T, Li SX, Gao H, Wang JT, and Shi WY
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Aged, Cornea surgery, Prostheses and Implants, Prosthesis Implantation, Blindness, Postoperative Complications surgery, Retrospective Studies, Corneal Diseases surgery, Glaucoma surgery, Corneal Perforation surgery, Artificial Organs
- Abstract
Objective: To evaluate the efficiency and safety of collar-button type keratoprosthesis (c-bKPro) implantation for corneal blindness in high-risk transplantation in China. Methods: It was a case series study. High-risk corneal blind patients who planned to undergo c-bKPro implantation were prospectively and continuously enrolled in the Eye Hospital of Shandong First Medical University, Ophthalmology Division of Chinese PLA General Hospital, Zhongshan Ophthalmic Center , Department of Ophthalmology in Eye & ENT Hospital of Fudan University, and Eye Hospital of Wenzhou Medical University from July 2019 to January 2020. The cure for blindness and surgical success were assessed based on visual acuity (VA)≥0.05. The complications and keratoprosthesis retention rate were recorded to determine the safety of the surgery. Results: Thirty-seven subjects (eyes) were included, of which 32 were male and 5 were female, aged 27 to 72 years old. The indications of c-bKPro implantation were corneal graft failure (21 eyes, 56.8%), chemical injury (8 eyes, 21.6%), thermal burn (5 eyes, 13.5%), unexplained corneal opacity (2 eyes, 5.4%), and corneal perforation (1 eye, 2.7%). Two patients withdrew from the clinical trial at 3 months postoperatively. Thirty-five patients were followed up for 6 months, and 31 were followed up for 12 months. The VA was ≥0.05 in 83.8% of eyes at 6 months and in 81.8% of eyes at 12 months. Among the 11 eyes diagnosed with concurrent glaucoma, 6 eyes achieved a VA of ≥0.05. At 12 months, the c-bKPro retention rate was 100%. The surgical complications included retroprosthetic membrane formation (5 eyes, 16.1%), persistent corneal epithelial defects (5 eyes, 16.1%), macular edema (4 eyes, 12.9%), new-onset glaucoma (4 eyes, 12.5%; including one eye withdrawn from the study at 3 months), sterile corneal melting (2 eyes, 6.5%), sterile vitritis (1 eye, 3.2%), and infectious keratitis (1 eye, 3.2%). Conclusions: C-bKPro implantation is an effective and safe option for treating corneal blindness in high-risk transplantation in China. Improved visual outcomes could be achieved in most cases, with a relatively low incidence of postoperative complications.
- Published
- 2023
- Full Text
- View/download PDF
15. [Interpretiation of guidelines for the diagnosis and management of aplastic anemia in China (2022)].
- Author
-
Fu R and Wang T
- Subjects
- Humans, Immunosuppressive Agents, Cyclosporine, China, Anemia, Aplastic diagnosis, Anemia, Aplastic therapy
- Published
- 2023
- Full Text
- View/download PDF
16. [Efficacy and safety of neoadjuvant chemotherapy combined with PD-1 antibody for esophageal squamous cell carcinoma in the real world].
- Author
-
Wu PY, Wang T, Chen BJ, Shi MK, Huang B, Wu ND, Qi L, Chang XF, Wang LF, Liu BR, and Ren W
- Subjects
- Humans, Antibodies therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Immune Checkpoint Inhibitors therapeutic use, Neoadjuvant Therapy, Programmed Cell Death 1 Receptor therapeutic use, Retrospective Studies, Treatment Outcome, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell surgery, Esophageal Neoplasms drug therapy, Esophageal Neoplasms surgery, Esophageal Squamous Cell Carcinoma drug therapy
- Abstract
Objective: To evaluate the efficacy and safety of neoadjuvant chemotherapy combined with programmed death-1 (PD-1) antibody in operable, borderline or potentially resectable locally advanced esophageal squamous cell carcinoma(ESCC) in the real world. Methods: The study retrospectively analyzed 28 patients with operable or potentially resectable locally advanced ESCC patients treated with preoperative chemotherapy combined with PD-1 inhibitor in Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School from April 2020 to March 2021. According to the clinical TNM staging system of the 8th edition of the American Joint Committee on Cancer, there were 1, 15, 10, 1 and 1 case of stage Ⅱ, Ⅲ, ⅣA, ⅣB and unknown stage respectively. The treatment was two cycle of dual drug chemotherapy regimen including taxane plus platinum or fluorouracil combined with PD-1 antibody followed by tumor response assessment and surgery if the patient was eligible for resection. Results: Of the 28 patients, 1, 2, 3 and 4 cycles of chemotherapy combined with PD-1 antibody treatment completed in 1, 21, 5, and 1 patient, respectively. Objective response rate (ORR) was 71.4% (20/28), and disease control rate (DCR) was 100% (28/28). The incidence of adverse events exceeding grade 3 levels was 21.4% (6/28), including 3 neutropenia, 1 leukopenia, 1 thrombocytopenia and 1 immune hepatitis. There was no treatment-related death. Of the 23 patients underwent surgery, R0 resection rate was 87.0% (20/23), 13 patients had down staged to the T1-2N0M0 I stage, the pCR rate was 17.3% (4/23), and the pCR rate of primary tumor was 21.7% (5/23). Four patients received definitive chemoradiotherapy. One patient rejected surgery and other treatment after achieved PR response. Conclusion: Neoadjuvant chemotherapy combined PD-1 inhibitor is safe and has high efficacy in operable, borderline or potentially resectable locally advanced ESCC, and it is a promising regimen.
- Published
- 2023
- Full Text
- View/download PDF
17. [The role and mechanism of tumor metastasis-associated gene 1 in radiosensitivity of HeLa cells].
- Author
-
Sun FZ, Wang JS, Li CX, Wang T, Zhang JY, Zhou YT, Wang HJ, and Qian HL
- Subjects
- Apoptosis genetics, Caspase 3 metabolism, Female, HeLa Cells, Humans, Poly(ADP-ribose) Polymerase Inhibitors, Radiation Tolerance genetics, Repressor Proteins genetics, Repressor Proteins metabolism, Trans-Activators genetics, Trans-Activators metabolism, Uterine Cervical Neoplasms genetics, Uterine Cervical Neoplasms metabolism, Uterine Cervical Neoplasms radiotherapy
- Abstract
Objective: To determine the effect of tumor metastasis-associated gene 1 (MTA1) on the sensitivity of HeLa cells to radiotherapy, and to clarify its molecular mechanism. Methods: The transcriptome differences between MTA1 knocked down Hela cells and control cells were analyzed, and the differentially expressed genes (DEGs) was used to perform Gene-Set Enrichment Analysis (GSEA) and Gene Ontology (GO) cluster analysis. Flow cytometry was used to detect apoptosis in MTA1-overexpressed HeLa cells and control cells before and after 10 Gy X-ray irradiation. Cloning formation assay and real-time cellular analysis (RTCA) were used to monitor the cell proliferation before and after 2 Gy X-ray irradiation. To dissect the underlying molecular mechanisms of MTA1 affecting the sensitivity of radiotherapy, the proteins encoded by the DEGs were selected to construct a protein-protein interaction network, the expression of γ-H2AX was detected by immunofluorescence assay, and the expression levels of γ-H2AX, β-CHK2, PARP and cleaved caspase 3 were measured by western blot. Results: By transcriptome sequencing analysis, we obtained 649 DEGs, of which 402 genes were up-regulated in MTA1 knockdown HeLa cells and 247 genes were down-regulated. GSEA results showed that DEGs associated with MTA1 were significantly enriched in cellular responses to DNA damage repair processes. The results of flow cytometry showed that the apoptosis rate of MTA1 over-expression group (15.67±0.81)% after 10 Gy X-ray irradiation was significantly lower than that of the control group [(40.27±2.73)%, P <0.001]. After 2 Gy X-ray irradiation, the proliferation capacity of HeLa cells overexpressing MTA1 was higher than that of control cells ( P =0.024). The numbers of colon in MTA1 over-expression group before and after 2 Gy X-ray irradiation were (176±7) and (137±7) respectively, higher than (134±4) and (75±4) in control HeLa cells ( P <0.05). The results of immunofluorescence assay showed that there was no significant expression of γ-H2AX in MTA1 overexpressed and control HeLa cells without X-ray irradiation. Western blot results showed that the expression level of β-CHK2 in MTA1-overexpressing HeLa cells (1.04±0.06) was higher than that in control HeLa cells (0.58±0.25, P =0.036) after 10 Gy X-ray irradiation. The expression levels of γ-H2AX, PARP, and cleaved caspase 3 were 0.52±0.13, 0.52±0.22, and 0.63±0.18, respectively, in HeLa cells overexpressing MTA1, which were lower than 0.87±0.06, 0.78±0.12 and 0.90±0.12 in control cells ( P >0.05). Conclusions: This study showed that MTA1 is significantly associated with radiosensitivity in cervical cancer HeLa cells. MTA1 over-expression obviously reduces the sensitivity of cervical cancer cells to X-ray irradiation. Mechanism studies initially indicate that MTA1 reduces the radiosensitivity of cervical cancer cells by inhibiting cleaved caspase 3 to suppress apoptosis and increasing β-CHK2 to promote DNA repair.
- Published
- 2022
- Full Text
- View/download PDF
18. [Relationship between etiology and morphological classification of benign central airway stenosis and its prognosis].
- Author
-
Fang XY, Zhang J, Wang T, Chen F, Peng YH, and Jin BB
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Constriction, Pathologic etiology, Female, Humans, Iatrogenic Disease, Intubation, Intratracheal adverse effects, Male, Middle Aged, Postoperative Complications, Prognosis, Retrospective Studies, Young Adult, Foreign Bodies complications, Tracheal Stenosis etiology, Tracheal Stenosis therapy, Tuberculosis complications
- Abstract
Objectives: To analyze the relationship between etiology and morphological classification of benign central airway stenosis and its prognosis. Methods: We performed a retrospective study of the medical records of 453 patients initially diagnosed with benign airway stenosis at Department of Respiratory Diseases in Beijing Tiantan Hospital affiliated to Capital Medical University from January 2003 to October 2019. Of 453 patients, 260 were male. The age of the study population was 12-86(44.0±24.5) years. Results: Among the 453 patients diagnosed with benign central airway stenosis, 161 case (35.5%, including 113 post-tracheostomy tracheal stenosis and 48 post-intubation tracheal stenosis) were iatrogenic; 88 cases were from benign tumors (19.4%), 77 cases from tracheal or bronchial tuberculosis (17.0%), 71 case from tracheal foreign bodies (15.7%). Disease causes varied among different gender or age groups. The main type of stenosis was structural stenosis, of which 241 cases (53.2%) were intra-luminal and 183 cases (40.4%) were scar contracture type. The site of stenosis showed a certain relationship with the causes of stenosis. The stenosis degree was mainly from grade 2 to grade 4 (76.4%), and the length was mainly within 3 cm (84.8%). Single factor analysis on the relationship between disease cause, morphological classification and prognosis of benign central airway stenosis showed statistically better prognosis in groups that were caused by benign tumor, intraductal stenosis or stenosis that were 3-4 in degree and 1-2 degree in length. Conclusion: The common causes of central airway stenosis included iatrogenic stenosis, benign tumor, tracheal or bronchial tuberculosis and tracheal foreign bodies. Benign airway stenosis with different disease causes and morphological classification had different prognosis after bronchoscopic interventional treatment. Clinicians should know the disease causes, morphological characterization and risk factors for benign airway stenosis for earlier diagnosis, treatment or prevention.
- Published
- 2022
- Full Text
- View/download PDF
19. [Efficacy of stanozolol and danazol in the treatment of non-severe aplastic anemia and their effects on CD4(+)CD25(+)Foxp3(+) regulatory T cells].
- Author
-
Li HM, Long ZB, Wang T, and Han B
- Subjects
- CD4-Positive T-Lymphocytes, Forkhead Transcription Factors, Humans, Interleukin-2 Receptor alpha Subunit, Stanozolol, T-Lymphocytes, Regulatory, Transcription Factors, Anemia, Aplastic drug therapy, Danazol
- Published
- 2022
- Full Text
- View/download PDF
20. [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
- Author
-
Fu WH, Chen PL, Xia JL, Fu L, Shen Y, He WJ, Chen YH, Ren N, Jiang Q, Ma R, Wang T, Wang XN, Zhang NF, and Liu CL
- Subjects
- Antihypertensive Agents therapeutic use, Bosentan, Endothelin Receptor Antagonists therapeutic use, Humans, Network Meta-Analysis, Treatment Outcome, Phosphodiesterase 5 Inhibitors therapeutic use, Pulmonary Arterial Hypertension
- Abstract
Objective: To examine the efficacy and safety of endothelin receptor antagonists (ERA) combined with phosphodiesterase 5 inhibitors (PDE5i) in the treatment of pulmonary artery hypertension (PAH). Methods: Computer-based retrieval was performed on PubMed, Cochrane Library, CNKI, Wanfang, and VIP database (up to February 12th, 2021). Randomized controlled trials about endothelin receptor antagonists (ERAs) or PDE5i in patients with PAH were collected. The change of 6-minute walking distance (6MWD) in 12-16 weeks was used as primary outcome index. Case fatality rate, worsening clinical events, WHO functional class (FC) improvement, adverse events (AEs), serious adverse events (SAE) were the key secondary outcomes indicators. STATA 16.0 software was used for network meta-analysis, and the pooled estimates of odds ratios ( OR s) or weighted mean differences (WMDs) and 95% confidence intervals ( CI s) of the results were shown. To help explain OR s and WMDs, we used the surface under the cumulative ranking curve (SUCRA) to calculate the probability of each intervention. Results: We included 29 trials with 5 949 participants. In network meta-analysis, Bosentan combined with Sildenafil ( WMD =53.93, 95% CI =6.19-101.66) had shown the greatest improvement in 6MWD compared with placebo, followed by Bosentan combined with Tadalafil ( WMD =50.84, 95% CI =7.05-94.62), Ambrisentan combined with Tadalafil ( WMD =46.67, 95% CI =15.88-77.45), Bosentan ( WMD =29.44, 95% CI =5.86-53.02), Ambrisentan ( WMD =23.90, 95% CI =0.31-47.48) and Macitentan ( WMD =21.57, 95% CI =2.45-40.69). According to SUCRA, the effects of different intervention measures on improving 6MWD in patients with arterial pulmonary hypertension were as follows: Bosentan+Sildenafil (82.9%)>Bosentan+Tadalafil (78.4%)>Ambrisentan+Tadalafil (77.1%)>Bosentan (49.2%)>Sildenafil (48.5%)>Ambrisentan (40.3%)>Macitentan (37.3%)>Tadalafil (33.0%)>Placebo (3.3%). For the WHO functional class, Sildenafil ( OR =2.90, 95% CI =1.04-8.08) was optimal compared with placebo, followed by Bosentan ( OR =2.15, 95% CI =1.15-4.04), and there was no significant difference in the rest. For clinical worsening, Bosentan combined with Tadalafil ( OR =0.08, 95% CI =0.01-0.49) performed best compared with placebo, followed by Bosentan ( OR =0.20, 95% CI =0.11-0.38), Bosentan combined with Sildenafil ( OR =0.21, 95% CI =0.09-0.46), Ambrisentan combined with Tadalafil ( OR =0.27, 95% CI =0.15-0.50), Sildenafil ( OR =0.33, 95% CI =0.17-0.66) and Tadalafil ( OR =0.44, 95% CI =0.21-0.90). There was no statistical difference between all interventions and placebo in terms of the incidence of adverse events and serious adverse events. For case fatality rate, Ambrisentan ( OR =0.28, 95% CI =0.11-0.74) was statistically superior to placebo and there was no statistics difference in the rest. Conclusions: The combination therapy of ERAs and PDE5i performed well in the short-term improvement of motor function. Furthermore, there was no significant difference with monotherapy in terms of safety. However, it is worth emphasizing that the choice of treatment should be based on the patient's individualized situation and the patient's requirements.
- Published
- 2022
- Full Text
- View/download PDF
21. [Annual review of interventional pulmonology (2021)].
- Author
-
Wang T and Zhang J
- Subjects
- Bronchoscopy, Research, Pulmonary Medicine
- Abstract
In the last decade, interventional pulmonology has developed rapidly, and gradually become a mature subspecialty in modern respiratory medicine, playing a more and more important role in the diagnosis and treatment of respiratory diseases. Especially in recent years, with the development of the related technology, various new technologies of interventional pulmonology came out and are gradually applied to chronic respiratory diseases which were mainly treated with drugs before, greatly expanding the application field of interventional pulmonology. Here, we reviewed the new progress and up-to-date research achievements of interventional pulmonology from 2020 to 2021.
- Published
- 2022
- Full Text
- View/download PDF
22. [Efficacy and safety of Montgomery T-tube placement for benign complex subglottic tracheal stenosis: a retrospective analysis of 29 cases].
- Author
-
Jin BB, Wang J, Wang YL, Qiu XJ, Pei YH, Wang T, and Zhang J
- Subjects
- Humans, Intubation, Intratracheal adverse effects, Postoperative Complications epidemiology, Retrospective Studies, Trachea, Tracheal Stenosis etiology, Tracheal Stenosis surgery
- Abstract
Objective: To analyze the efficacy and safety of Montgomery T-tube (T-tube) placement for benign complex subglottic tracheal stenosis. Methods: A retrospective analysis of the clinical data of 29 patients with benign complex subglottic tracheal stenosis receiving T-tube placement in Beijing Tiantan Hospital from May 2015 to December 2019. The causes were postintubation tracheal stenosis [27 cases (93.1%), including 21 cases (72.4%) of tracheal stenosis after tracheotomy, 6 cases (20.7%) of tracheal stenosis after tracheal intubation], cervical post-traumatic tracheal stenosis (1 case, 3.4%) and tuberculous tracheal stenosis (1 case, 3.4%), respectively. Three-dimensional reconstruction of tracheal computerized tomography (CT) and bronchoscopy were used to grade the stenosis according to Cotton-Myer classification system before bronchoscopic intervention. The degree of stenosis was Cotton-Myer grade Ⅱ (7 cases, 24.1%), grade Ⅲ (11 cases, 37.9%) and grade Ⅳ (11 cases, 37.9%), respectively. All cases received placement of T-tubes and follow-up. Fisher's exact test was used for comparison between groups. Results: T-tube placement was performed 39 times in 29 patients. T-tubes were successfully placed for 24 cases (82.8%). The main complication during the operation was tracheal mucosal tear (6 cases, 20.7%), which resolved in all cases within 2 weeks. The main postoperative complication was secretion retention (27 cases, 93.1%), which was relieved after home nebulization treatment in 26 cases; and followed by granulation hyperplasia, especially located in T-tube upper margin (12 cases, 41.4%), of which 8 cases were cured after bronchoscopic intervention. None of the patients had T-tube migration. There were no statistically significant differences in the success rate of T-tube placement and the incidence of major complications in patients with benign complex subglottic tracheal stenosis with different degrees of stenosis. After 18 months to 24 months of follow-up, attempt was made to remove the T-tube in 9 patients but failed in 4 patients. The failure was due to collapse of the airway after the T-tube was removed. Conclusion: T-tube placement is a safe and reliable treatment for benign complex subglottic tracheal stenosis with high efficiency and manageable complications.
- Published
- 2021
- Full Text
- View/download PDF
23. [Application of robotic-assisted bronchoscopy in the diagnosis of peripheral lung lesions].
- Author
-
Wang T and Zhang J
- Subjects
- Lung diagnostic imaging, Bronchoscopy, Robotic Surgical Procedures
- Published
- 2021
- Full Text
- View/download PDF
24. [Recent advances of chronic cough].
- Author
-
Zhang YN, Wang T, Liu DX, Xu S, and Zhu ZQ
- Subjects
- Chronic Disease, Humans, Cough
- Published
- 2021
- Full Text
- View/download PDF
25. [Multiple myeloma with multiple extramedullary lesions of pancreas, stomach and skin: a case report].
- Author
-
Wang T, Xie J, and Song FX
- Subjects
- Humans, Pancreas, Stomach, Multiple Myeloma
- Published
- 2021
- Full Text
- View/download PDF
26. [Establishment of an auxiliary diagnosis system of newborn screening for inherited metabolic diseases based on artificial intelligence technology and a clinical trial].
- Author
-
Yang RL, Yang YL, Wang T, Xu WZ, Yu G, Yang JB, Sun QL, Gu MS, Li HB, Zhao DH, Pei JY, Jiang T, He J, Zou H, Mao XM, Geng GX, Qiang R, Tian GL, Wang Y, Wei HW, Zhang XG, Wang H, Tian YP, Zou L, Kong YY, Zhou YX, Ou MC, Yao ZR, Zhou YL, Zhu WB, Huang YL, Wang YH, Huang CD, Tan Y, Li L, Shang Q, Zheng H, Lyu SL, Wang WJ, Yao Y, Le J, and Shu Q
- Subjects
- Artificial Intelligence, China, Humans, Infant, Infant, Newborn, Retrospective Studies, Single-Blind Method, Technology, Metabolic Diseases, Neonatal Screening
- Abstract
Objective: To establish a disease risk prediction model for the newborn screening system of inherited metabolic diseases by artificial intelligence technology. Methods: This was a retrospectively study. Newborn screening data ( n= 5 907 547) from February 2010 to May 2019 from 31 hospitals in China and verified data ( n =3 028) from 34 hospitals of the same period were collected to establish the artificial intelligence model for the prediction of inherited metabolic diseases in neonates. The validity of the artificial intelligence disease risk prediction model was verified by 360 814 newborns ' screening data from January 2018 to September 2018 through a single-blind experiment. The effectiveness of the artificial intelligence disease risk prediction model was verified by comparing the detection rate of clinically confirmed cases, the positive rate of initial screening and the positive predictive value between the clinicians and the artificial intelligence prediction model of inherited metabolic diseases. Results: A total of 3 665 697 newborns ' screening data were collected including 3 019 cases ' positive data to establish the 16 artificial intelligence models for 32 inherited metabolic diseases. The single-blind experiment ( n =360 814) showed that 45 clinically diagnosed infants were detected by both artificial intelligence model and clinicians. A total of 2 684 cases were positive in tandem mass spectrometry screening and 1 694 cases were with high risk in artificial intelligence prediction model of inherited metabolic diseases, with the positive rates of tandem 0.74% (2 684/360 814)and 0.46% (1 694/360 814), respectively. Compared to clinicians, the positive rate of newborns was reduced by 36.89% (990/2 684) after the application of the artificial intelligence model, and the positive predictive values of clinicians and artificial intelligence prediction model of inherited metabolic diseases were 1.68% (45/2 684) and 2.66% (45/1 694) respectively. Conclusion: An accurate, fast, and the lower false positive rate auxiliary diagnosis system for neonatal inherited metabolic diseases by artificial intelligence technology has been established, which may have an important clinical value.
- Published
- 2021
- Full Text
- View/download PDF
27. [Application of pegylated recombinant human granulocyte colony stimulating factor in mobilization of autologous peripheral blood stem cells].
- Author
-
Wang T, Feng R, Li JT, Ning SY, Yang YZ, Zhang CL, Bai JF, and Liu H
- Subjects
- Granulocyte Colony-Stimulating Factor, Hematopoietic Stem Cell Mobilization, Humans, Polyethylene Glycols, Recombinant Proteins, Transplantation, Autologous, Hematopoietic Stem Cell Transplantation, Peripheral Blood Stem Cells
- Published
- 2021
- Full Text
- View/download PDF
28. [Efficacy and influencing factors of interventional bronchoscopy for the treatment of scarring airway stenosis: a multicenter retrospective investigation from China].
- Author
-
Wang T, Zhang J, Qiu XJ, Wang J, Pei YH, and Wang YL
- Subjects
- China, Cicatrix, Constriction, Pathologic, Humans, Retrospective Studies, Treatment Outcome, Airway Obstruction, Bronchoscopy
- Abstract
Objectives: To evaluate the efficacy of interventional bronchoscopy for the treatment of scarring airway stenosis and to analyze the influencing factors related to the success rate. Methods: Between January 2013 to December 2016, 301 patients with scarring airway stenosis treated by interventional bronchoscopy in 18 tertiary hospitals were reviewed retrospectively. The methods of interventional bronchoscopy included electric knife cutting, laser cauterization, balloon dilation, cryotherapy, local drug usage and/or stenting. Airway stenosis characteristics and patients' performance status at baseline and after interventional bronchoscopy were recorded. The interval days between the first two interventional bronchoscopy treatment (maintained patency time) and the final treatment efficacy were recorded. Results: The clinical stability rate of interventional bronchoscopy for the treatment of scarring tracheal stenosis was 67.8% (204/301) . Stenosis sites ( OR 1.548; 95% CI: 1.038-2.307, P= 0.032) , dyspnea index ( OR 2.140; 95% CI: 1.604-2.855, P< 0.001) , and interventional method ( OR 0.458; 95% CI: 0.267-0.787, P= 0.005) were independent predictors associated with the efficacy of interventional bronchoscopy treatment. Stenosis sites ( OR 1.508; 95% CI: 1.273-1.787, P< 0.001) , stenosis grade ( OR 1.581; 95% CI: 1.029-2.067, P= 0.001) , anesthesia method ( OR 1.581; 95% CI: 1.029-2.067, P< 0.001) , and local drug usage ( OR 1.304; 95% CI: 1.135-1.497, P< 0.001) were independent predictors associated with the maintained patency time after first interventional bronchoscopy treatment. Conclusion: Interventional bronchoscopy is a useful treatment method for scarring airway stenosis. Enough attention should be paid to influencing factors in order to improve treatment efficacy during the treatment process.
- Published
- 2020
- Full Text
- View/download PDF
29. [Primary effusion lymphoma in a HIV-negative patient: case report and literatures review].
- Author
-
Song YF, Liu H, Bai JF, Ke HX, Li JT, Wang T, Yang YZ, Yin JJ, and Feng R
- Subjects
- Humans, HIV Seronegativity, Lymphoma, Primary Effusion diagnosis
- Published
- 2020
- Full Text
- View/download PDF
30. [Efficacy of double-incision extracapsular cataract extraction in the treatment of hard-nucleus cataract with low corneal endothelial cell density].
- Author
-
Jiang Y, Shi WY, Li FJ, and Wang T
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Retrospective Studies, Astigmatism, Cataract, Cataract Extraction, Endothelial Cells
- Abstract
Objective: To discuss the efficacy and security of double-incision extracapsular cataract extraction (ECCE) in the treatment of hard-nucleus cataract with low corneal endothelial cell density. Methods: This was a retrospective case series study. Forty-six patients (47 eyes) with hard-nucleus cataract and low corneal endothelial cell density were enrolled at Shandong Eye Hospital from June 2009 to December 2018, including 22 males and 24 females, aged 50 to 74 (63.8±6.3) years. Preoperative corneal endothelial cell density was less than 1 000 cells/mm(2), and the cataract nuclear hardness was equal to or greater than grade IV. According to the surgical methods, the patients were divided into the single-incision ECCE group (24 eyes) and the double-incision ECCE group (23 eyes). The surgical procedures for the double-incision group were as follows. First, a superior scleral pre-incision was made. Then the conventional capsulorhexis was conducted through a 2.6 mm transparent corneal tunnel incision at the temporal or the nasal side, after which the hydro-dissection was performed. Next, the surgeon cut the pre-incision at the sclera, delivered the lens nucleus, sutured the scleral incision and removed the residual cortical materials from the corneal incision. Finally, a foldable intraocular lens was implanted, and the viscoelastic substance was removed. The intraoperative anterior chamber condition and the postoperative corneal edema condition were monitored. During the 6 month follow-up after surgeries, the endothelium cell density, visual acuity and astigmatism in the two groups were compared. The χ(2) test was used to compare the counting data, and the t test was used to compare the measurement data. Results: There was no statistically significant difference ( t= 1.12, P= 0.28) in the preoperative corneal endothelial cell density between the double-incision and single-incision ECCE groups, which was (827±164) cells/mm(2) and (802±121) cells/mm(2), respectively. At 6 months after operation, in the double-incision and single-incision groups, the endothelial cell density was (793±147) cells/mm(2) and (706±101) cells/mm(2), respectively, and the difference was statistically significant ( t= 4.37, P< 0.01). The percentage of corneal endothelial cell loss was 4.16%±3.12% and 11.69%±2.96%, respectively, and the difference was also statistically significant ( t= 9.52, P< 0.01). The hexagon loss rate of corneal endothelial cells was 9.67%±6.11% and 28.33%±8.39%, respectively, and the difference was statistically significant ( t= 5.52, P< 0.05). In the follow-up of 6 months, none of the eyes in the double-incision ECCE group suffered corneal endothelial decompensation compared with 3 eyes in the single-incision ECCE group. There were no statistically significant differences in postoperative astigmatism and surgically induced astigmatism between the two groups ( t= -0.71, 0.15; P> 0.05). Conclusions: The double-incision ECCE, in which the lens nucleus is delivered through a scleral incision and other procedures are conducted through a corneal tunnel incision, is safe and effective for cataract patients with hard nucleus and low corneal endothelial cell density. (Chin J Ophthalmol, 2020, 56: 126-130) .
- Published
- 2020
- Full Text
- View/download PDF
31. [Analysis of population attributable risk of large for gestational age].
- Author
-
Zheng W, Zhang L, Tian ZH, Zhang T, Wang T, Yan Q, Li GH, and Zhang WY
- Subjects
- Birth Weight, Body Mass Index, China epidemiology, Female, Fetal Macrosomia etiology, Gestational Age, Humans, Obesity epidemiology, Overweight complications, Overweight epidemiology, Pregnancy, Pregnancy Complications epidemiology, Retrospective Studies, Weight Gain, Diabetes, Gestational epidemiology, Fetal Macrosomia epidemiology, Obesity complications
- Abstract
Objective: To examine the association of pre-pregnancy obesity, excessive gestational weight gain (GWG) and gestational diabetes mellitus (GDM) with the risk of large for gestational age (LGA), and assess the dynamic changes in population attributable risk percent (PAR%) for having these exposures. Methods: A retrospective cohort study was conducted to collect data on pregnant women who received regular health care and delivered in Beijing Obstetrics and Gynecology Hospital from January to December in 2011, 2014 and 2017, respectively. Information including baseline characteristics, metabolic indicators during pregnancy, pregnancy complications, and pregnancy outcomes were collected. Multivariate logistic regression model was constructed to assess their association with LGA delivery. Adjusted relative risk and prevalence of these factors were used to calculate PAR%and evaluate the comprehensive risk. Results: (1)The number of participants were 11 132, 13 167 and 4 973 in 2011, 2014 and 2017, respectively. Corresponding prevalence of LGA were 15.19% (1 691/11 132), 14.98% (1 973/13 167) and 16.21% (806/4 973). No significant change in the prevalence of LGA was observed across all years investigated (all P >0.05). (2)According to results from multivariate logistic regression model, advanced maternal age, multiparity, pre-pregnancy overweight or obesity, GWG,GDM and serum triglyceride level≥1.7 mmol/L in the first trimester were associated with high risk of LGA (all P <0.05). Among these factors, pre-pregnancy overweight or obesity, excessive GWG and multiparity were common risk factors of LGA. GDM was not associated with risk of LGA in 2017 database. (3) Dynamic change of PAR% in these years were notable. PAR% of GWG for LGA decreased (32.6%, 27.2% and 22.2% in 2011, 2014 and 2017, respectively), while PAR% of pre-pregnancy overweight or obesity showed an upward trend (4.2%, 3.3% and 8.4%). In addition, PAR% of multiparity increased as well (3.5%, 6.3% and 15.9%). (4) Further analysis showed that excessive GWG in the first and second trimesters contributed the most (20.2% and 19.0% in 2014 and 2017). Conclusions: Excessive GWG, pre-pregnancy overweight or obesity and multiparity are the important risk factors what contribute to LGA. PAR% of excessive GWG for LGA decrease in recent years. However, GWG in the first and second trimesters is a critical factor of LGA. Appropriate weight management in pre-pregnancy, the first or second trimester is the key point to reduce the risk of LGA.
- Published
- 2019
- Full Text
- View/download PDF
32. [Lenalidomide, rituximab and dexamethasone for the treatment of recurrent/refractory or elderly newly diagnosed patients with primary central nervous system lymphoma: 5 cases report and literature review].
- Author
-
Bai JF, Feng R, Han HX, Wang T, Li JT, Zhang CL, and Liu H
- Subjects
- Aged, Dexamethasone therapeutic use, Humans, Lenalidomide therapeutic use, Neoplasm Recurrence, Local, Rituximab therapeutic use, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Central Nervous System Neoplasms drug therapy, Lymphoma drug therapy
- Published
- 2019
- Full Text
- View/download PDF
33. [Interactions between clonality and aplastic anemia].
- Author
-
Wang T and Fu R
- Subjects
- Bone Marrow, Humans, Anemia, Aplastic, Myelodysplastic Syndromes
- Published
- 2019
- Full Text
- View/download PDF
34. [Clinical analysis of the timing and efficacy of allogeneic stem cell transplantation for severe aplastic anemia with infections].
- Author
-
Wang T, Ma LM, Zhu QJ, Gong R, Gao ZL, and Tian WW
- Subjects
- Humans, Transplantation Conditioning, Anemia, Aplastic, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Infections
- Published
- 2019
- Full Text
- View/download PDF
35. [Nocardia infection after allogeneic hematopoietic stem cell transplantation: two cases report and literature review].
- Author
-
Song HZ, Gao L, Xu LL, Wang T, Ni X, and Yang JM
- Subjects
- Humans, Transplantation, Homologous, Hematopoietic Stem Cell Transplantation, Nocardia Infections
- Published
- 2019
- Full Text
- View/download PDF
36. [Comparison of IA and HAD for induction remission therapy of FLT3-ITD positive acute myeloid leukemia patients].
- Author
-
Wang T, Ma LM, Zhu QJ, Gong R, Gao ZL, and Tian WW
- Subjects
- Humans, Mutation, Prognosis, Remission Induction, fms-Like Tyrosine Kinase 3, Leukemia, Myeloid, Acute
- Published
- 2019
- Full Text
- View/download PDF
37. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
- Author
-
Wang T, Tan YJ, Wu SJ, Huang M, Yin BT, Huang J, Wei N, Wei W, and Wang F
- Subjects
- Case-Control Studies, Female, Humans, Interferon-gamma, Latent Tuberculosis microbiology, Male, ROC Curve, Retrospective Studies, Sensitivity and Specificity, Tuberculosis microbiology, Antigens, Bacterial analysis, Latent Tuberculosis diagnosis, Mycobacterium immunology, Mycobacterium tuberculosis isolation & purification, Phytohemagglutinins analysis, Tuberculosis diagnosis
- Abstract
Objective: The aim of this study was to determine the performance of the ratio of tuberculosis-specific antigen (TBAg) to phytohemagglutinin (PHA) (TBAg/PHA ratio) in T-SPOT assay in the diagnosis of active tuberculosis (ATB). Methods: Between January 2014 and January 2017, 378 Mycobacterium tuberculosis (MTB) culture positive patients (268 cases of pulmonary tuberculosis, 110 extra-pulmonary tuberculosis) and 824 healthy individuals were recruited from Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. T-SPOT assay was performed and TBAg/PHA ratio was calculated in all the participants. To validate the study, another group of 223 MTB culture positive TB patients with positive T-SPOT results were recruited from Guangzhou Chest Hospital between January 2017 and December 2017. This was a retrospective case-control study and differences between groups were analyzed using the Mann-Whitney U-test. Results: Of the 378 culture positive ATB patients, 344 patients had positive T-SPOT results. Of the 824 healthy individuals, 204 individuals had positive T-SPOT results. Using healthy individuals as the control group, the sensitivity and specificity of T-SPOT assay in the diagnosis of ATB were 91.0% (344/378) and 75.2% (620/824). Directly using T-SPOT results had a limited accuracy in distinguishing ATB from latent tuberculosis infection (LTBI). The area under the receiver operating characteristic (ROC) curve was between 0.7 and 0.8. However, a further calculation of the TBAg/PHA ratio showed a better performance than TBAg in distinguishing these two conditions, and the area under the ROC curve was 0.881 (95% CI: 0.853-0.909). If using the threshold value of 0.234, the sensitivity and specificity of the TBAg/PHA ratio in distinguishing ATB from LTBI were 69.5% (239/344) and 94.12% (192/204). The validation data showed that the performance of the TBAg/PHA ratio in distinguishing ATB from LTBI was also satisfactory, and the area under the ROC curve was 0.901 (95% CI: 0.872-0.931). Furthermore, the TBAg/PHA ratio had an important role in the diagnosis of extra-pulmonary tuberculosis. If using the threshold value of 0.234, the sensitivity and specificity of the TBAg/PHA ratio in the diagnosis of extra-pulmonary tuberculosis were 79.2% (76/96) and 94.1% (192/204). The area under the ROC curve was 0.932 (95% CI: 0.897-0.967). Conclusions: The TBAg/PHA ratio in T-SPOT assay was better than directly using T-SPOT results in distinguishing ATB from LTBI. This ratio also showed a potential use in the diagnosis of extra-pulmonary tuberculosis.
- Published
- 2019
- Full Text
- View/download PDF
38. [The prognosis value of comprehensive geriatric assessment in elder patients with acute myeloid leukemia in a single center].
- Author
-
Bai JF, Mei D, Han HX, Zhang S, Feng R, Li JT, Wang T, Zhang CL, Ning SY, and Liu H
- Subjects
- Aged, Comorbidity, Humans, Prognosis, Geriatric Assessment, Leukemia, Myeloid, Acute
- Abstract
Objective: To evaluate the prognostic significance of comprehensive geriatric assessment (CGA) in Chinese elderly acute myeloid leukemia (AML) patients. Methods: 73 AML patients over the age of 60 were enrolled. CGA stratification included the following 3 instrument assessment: activity of daily living (ADL) ; instrumental activity of daily living (IADL) ; comorbidity score according to the Modified cumulative illness rating score for geriatrics (MCIRS-G) . According to CGA and age, the enrolled patients were grouped into 'fit', 'unfit' and 'frail' categories. Results: The median age of 73 elderly AML patients were 75 years old. According to CGA, 37 (50.1%) patients were classified as 'fit', 14 (19.2%) as 'unfit', and 22 (30.7%) as 'frail'. 33 (89.2%) patients in fit group received induction chemotherapy, or demethylation treatment, as 8 (57.9%) in unfit, 10 (45.5%) in frail. The overall response rate was 68.7%、62.5%, 75.0% in fit, unfit, and frail group, respectively ( χ (2)=0.615, P =0.769) .The early mortality (8 weeks) in three groups were different: 5.4%, 7.1%, 27.3%, respectively ( P <0.05) . The 1-year overall survival in the 'fit', 'unfit' and 'frail' groups was 64.9%, 28.6% and 22.7%, respectively ( P <0.05) . The CGA score, age, ECOG score, WHO classification (2016) were the prognostic factors of AML patients. Conclusion: CGA can be used to determine the prognosis of elderly AML patients.
- Published
- 2019
- Full Text
- View/download PDF
39. [A preliminary study of different methods of anesthesia for painless bronchoscopy].
- Author
-
Yuan Y, Zhang J, Yue HL, Wang J, Pei YH, Qiu XJ, Wang YL, and Wang T
- Subjects
- Anesthesia, Blood Pressure, Fentanyl administration & dosage, Fentanyl adverse effects, Humans, Lidocaine administration & dosage, Lidocaine adverse effects, Midazolam administration & dosage, Midazolam adverse effects, Outcome Assessment, Health Care, Oximetry, Pain Measurement, Propofol administration & dosage, Propofol adverse effects, Sufentanil administration & dosage, Sufentanil adverse effects, Bronchoscopy methods, Fentanyl therapeutic use, Heart Rate physiology, Lidocaine therapeutic use, Midazolam therapeutic use, Propofol therapeutic use, Sufentanil therapeutic use
- Abstract
Objective: This study aimed to explore a feasible method of anesthesia for painless bronchoscopy. Methods: A total of 120 patients receiving flexible bronchoscopy in Beijing Tiantan Hospital during the period from February, 8, 2018 to May, 4, 2018, were randomly divided into 3 groups, including group A (using lidocaine for local anesthesia), group B (using lidocaine + midazolam + fentanyl), and group C (using lidocaine + propofol + sufentanil). There were 41 patients in group A, 38 in group B and 41 in group C. The changes in systolic blood pressure, diastolic blood pressure, heart rate and pulse oxygen saturation(SpO(2)) in each group were recorded in different points of time. The safety of different methods of anesthesia was observed by recording vital signs and adverse events. Moreover, the visual analogue scale (VAS) was used to observe the patient's tolerance and satisfaction of the operation. Results: The intraoperative systolic blood pressure and diastolic blood pressure in group C were significantly lower than those in group A and B ( P< 0.05). Six cases in group C had hypotension, 3 of whom required vasoactive drugs. The differences of SpO(2) between the 3 groups showed no statistical significance ( P> 0.05), while patients in group C were prone to decrease in SpO(2). Eighteen patients in group C had hypoxemia during operation. But after treated with improving ventilation, the SpO(2) of those patients could be restored to normal. Compared with those in group C, patients in group A and group B showed significant discomfort, cough, and more pharyngeal pain ( P< 0.05). However, there were no significant differences in the degree of cough and pain between group A and group B ( P> 0.05). Most patients in group C had no uncomfortable sensation during the operation ( P< 0.05), and the willingness to re-examination was significantly higher than that in group A and group B ( P< 0.05). Conclusion: Propofol combined with sufentanil could achieve better painless effect, improve patient comfort and tolerance, and reduce intraoperative memory, but was prone to causing hypoxemia and hypotension. The decline of intraoperative SpO(2) could be corrected by establishing artificial airway, while the decrease of blood pressure could be corrected by applying vasoactive drugs, which were relatively safe.
- Published
- 2019
- Full Text
- View/download PDF
40. [Impact of interval between noeadjuvant chemoradiotherapy and surgery on short and long-term outcomes of patients with rectal cancer].
- Author
-
Zhang JS, Wang T, Du HP, and Wu L
- Subjects
- Humans, Neoadjuvant Therapy, Neoplasm Recurrence, Local, Neoplasm Staging, Rectal Neoplasms mortality, Rectal Neoplasms pathology, Rectal Neoplasms therapy, Time Factors, Treatment Outcome, Chemoradiotherapy, Adjuvant, Rectal Neoplasms surgery
- Abstract
Objective: To explore the best surgical timing after neoadjuvant chemoradiation for advanced rectal cancer patients. Methods: According to the time interval between neoadjuvant chemoradiation and surgery, 117 patients with advanced rectal cancer were divided into short interval group (≤7 weeks, n =54) and long interval group (>7 weeks, n =64). The endpoints included postoperative pathology, short-term efficacy, tumor recurrence and patient survival between the two groups. Results: There were 8 cases PCR in short interval group and 20 cases in long interval group( P =0.415). There were 23 cases of T downgrade in short interval group and 40 cases in the long interval group, which has significant difference ( P =0.039). There were 21 cases of N downgrade in short interval group and 38 cases in long interval group, which has significant different ( P =0.033). The short-term group was effective in 28 cases, stable in 20 cases, and progressed in 5 cases. In short term efficacy comparison, the cases of complete response, stable disease and progressive disease in short interval group was 28 cases, 20 and 5, long interval group was 47 cases, 14 cases and 3 cases, which has no significant difference( P =0.068). The 3-year local recurrence rate of short interval group and long interval group was 17.0% and 4.7%, respectively, and the difference was statistically significant( P =0.029). The incidence of recurrence in 3 years of short interval group and long interval group was 64.2% and 79.7%, respectively, and the difference was not significant ( P =0.061). The highest PCR rate was reached in the 10th and 11th week after neoadjuvant chemoradiotherapy. Of the 12 and 8 patients who underwent surgery, 3 (25.0%) and 2 (25.0%) achieved PCR, respectively. Conclusion: PCR and local recurrence rate might be improved by time interval between neoadjuvant chemoradiation and surgery was more than 7 weeks.
- Published
- 2018
- Full Text
- View/download PDF
41. [Advantages and disadvantages of preoperative artificial pneumothorax for medical thoracoscopy].
- Author
-
Hu W, Zhang J, Wang J, Pei YH, Wang YL, Qiu XJ, Wang T, Xu M, and Zhang CY
- Subjects
- Humans, Pleural Effusion, Pneumothorax, Retrospective Studies, Pleural Diseases diagnostic imaging, Pneumothorax, Artificial, Thoracoscopy
- Abstract
Objective: To expolre the indications, safety, advantages and disadvantages of performing artificial pneumothorax prior to medical thoracoscopy. Methods: Data of 152 patients undergoing medical thoracoscopy for pleural diseases in the Beijing Tiantan Hospital Affiliated to Capital Medical University from April 2007 to September 2014 were studied through retrospective analysis. According to the performance of artificial pneumothorax prior to medical thoracoscopy, the pleural space adhesions and the pleural effusions, patients were grouped into artificial pneumothorax group (107 cases) and non-artificial pneumothorax group (45 cases), adhesion group (102 cases) and non-adhesion group (50 cases), and few or no pleural effusion group (94 cases) and massive pleural effusion group (58 cases), respectively. The incidence of complications such as subcutaneous emphysema, pleural reaction, infection, aeroembolism and pulmonary injury/hemorrhage in different groups were compared, and the vital signs of patients were observed. Results were compared using the Chi square test. Results: After thoracoscopic examination, the definite diagnosis rates of artificial pneumothorax group and non- artificial pneumothorax group were 83.2% (89/107) and 93.3% (42/45) respectively, which showed no significant difference (χ(2)=2.744, P= 0.098). Three cases of subcutaneous emphysema occurred in the artificial pneumothorax group, while all these 3 cases belonged to adhesion group, and one of them belonged to few or no pleural effusion group, and 2 of them belonged to massive pleural effusion group. No subcutaneous emphysema cases were observed in the non-adhesion group. In the non-artificial pneumothorax group, one case of lung trauma caused by trocar was observed, which belonged to adhesion group and few or no pleural effusion group; no lung puncture wound cases were observed in massive pleural effusion group and non-adhesion group. Other complications related to artificial pneumothorax and thoracoscopy, such as pleural reaction, infection, air embolism and pulmonary injury/hemorrhage, were not observed. No significant changes were found between the vital signs of patients before and after artificial pneumothorax. Conclusion: For pleural effusion or pleural disease patients with pleural space adhesion, the performance of artificial pneumothorax prior to operation was recommended. Artificial pneumothorax was not recommended for patients without pleural space adhesions.
- Published
- 2018
- Full Text
- View/download PDF
42. [The clinical study of corneal cross-linking with preserved corneal epithelial flap in thin keratoconic corneas].
- Author
-
Sun JJ, Huang XJ, Shi WY, and Wang T
- Subjects
- Adolescent, Adult, Case-Control Studies, Cornea, Corneal Stroma, Cross-Linking Reagents, Female, Humans, Male, Prospective Studies, Ultraviolet Rays, Young Adult, Collagen therapeutic use, Keratoconus drug therapy, Photosensitizing Agents, Riboflavin therapeutic use
- Abstract
Objective: To evaluate the therapeutic effect of corneal collagen cross-linking (CXL) with preserved corneal epithelial flap and isotonic riboflavin for treatment of keratoconus eyes with thin corneas. Methods: Prospective case-control study. Twenty two eyes of 20 patients (16 males and 4 females, with age of 23.5±4.9), who have been diagnosed with progressive keratoeonus and the comeal stroma thickness of whom were less than 400μm (without the epithelium), were included in this study. Corneal collagen crosslinking was performed under preserved corneal epithelial flap (8.5mm), followed by instillation of 0.1% riboflavin and then UV irradiation. The corneal epithelial flap must be restored prior to the application of UVA irradiation. Visual acuity, corneal topography and endothelial cell count were evaluated at baseline and at 12 months follow-up. Data were analyzed using paired samples t test. Results: Corneal topography results of 12m before and after the therapy revealed the significant reductions of Kmax from (54.73±4.39)D to (53.46±3.85)D and Kmin from (48.97±3.72)D to (48.41±3.17)D, and also Km from (51.67±3.77) D to (50.77±3.28) D (Kmax: t=- 3.138, P< 0.05; Kmin: t=- 2.170, P< 0.05; Km: t=- 3.532, P< 0.05). No statistically significant differences were found between the average corneal thickness of pre therapy [(400.6±14.9) μm] and post therapy [(396.5±16.3)μm] ( t= 1.973, P> 0.05). Endothelial cell counts of pre therapy [(2 824±308)/mm(2)] and post therapy [(2 753±372)/mm(2)] were of no statistical significance as well ( t= 0.928, P> 0.05). No complications such as scarring lesions in the stroma and corneal endothelial damage were observed throughout the study period. Most of the patient's vision improved after treatment. Conclusion: The application of isotonic ribonavin solution in a cross-linking procedure in thin corneas with preserved corneal epithelial flap seems to be safe and effective as keratoconus tend to be stable at 12 months after therapy and no endothelial cell damage was caused. (Chin J Ophthalmol, 2018, 54: 421 - 425) .
- Published
- 2018
- Full Text
- View/download PDF
43. [Occurrence of radiation-induced injury in vagina after radical radiotherapy of cervical cancer and its affecting factors].
- Author
-
Zhang KS, Liu Z, Wang T, Wang J, Su J, Shi F, Wang RH, Yuan W, and Li Y
- Subjects
- Brachytherapy methods, China epidemiology, Cross-Sectional Studies, Female, Humans, Incidence, Radiation Dosage, Radiation Injuries epidemiology, Severity of Illness Index, Treatment Outcome, Uterine Cervical Neoplasms pathology, Brachytherapy adverse effects, Radiation Injuries diagnosis, Uterine Cervical Neoplasms radiotherapy, Vagina injuries, Vagina radiation effects
- Abstract
Objective: To investigate the occurrence and degree of radiation-induced injury in vagina after radical radiotherapy of cervical cancer. Methods: A total of 282 cases of patients with cervical cancer were collected from November 2016 to September 2017. All of the above patients underwent radical radiotherapy from 2008 to 2017 in the First Affiliated Hospital of Xi ' an Jiaotong University. The patients' International Federation of Gynecology and Obstetrics (FIGO) staging (2009) , brachytherapy dose, whether receive synchronous chemotherapy or not, age and body mass index (BMI) for the occurrence and severity of vaginal radiation injury at different time periods were analyzed by cross-sectional survey method. The single factor would be analyzed by the method of Chi-square test and the multiple factors would be analyzed by logistic regression method to checkout. Results: Of the 282 patients, the incidence of radiation-injury in vaginal was 84.4% (238/282) , with the incidence rate of degree Ⅰ,Ⅱ and Ⅲ radiation injury were respectively 50.7% (143/282), 29.8% (84/282) and 3.9% (11/282; χ(2)=153.375, P< 0.05) , and there was no degree Ⅳ. Until the end of the follow-up time, the incidence of radiation-induced injury in vaginal after completing the treatment within 1 year, 1-2 years,>2-<5 years and ≥5 years were respectively 80.0% (24/30) , 87.2% (102/117) , 88.2% (60/68) and 77.6% (52/67; χ(2)=4.231, P= 0.238) . There were 30 cases be followed within 1 year after treatment, the incidence rate of degreeⅠ,Ⅱ and Ⅲ of radiation injury in vagina was 60.0% (18/30) , 20.0% (6/30) and 0, respectively (χ(2)=28.636, P< 0.05). There were 117 cases be followed between 1-2 years after treatment, the incidence rate of degreeⅠ,Ⅱ and Ⅲ vaginal radiation-induced injury were 54.7% (64/117) , 29.9% (35/117) and 2.6% (3/117) , respectively (χ(2)=77.198, P< 0.05) . There were 68 cases be followed between >2-<5 years after treatment, the incidence rate of degree Ⅰ,Ⅱ and Ⅲ vaginal radiation-induced injury were 51.5% (35/68) ,33.8% (23/68) and 2.9% (2/68) , respectively (χ(2)=39.525, P< 0.05) . There were 67 cases be followed ≥5 years after treatment, the incidence rate of degree Ⅰ,Ⅱ and Ⅲ vaginal radiation injury were 38.8% (26/67) , 29.9% (20/67) and 9.0% (6/67) , respectively (χ(2)=16.395, P< 0.05) . The single-factor analysis result indicated that the brachytherapy dose had an obvious effect on vaginal radiation-induced injury (χ(2)=5.344, P= 0.021) ; however, other factors, such as age, BMI, FIGO stages and synchronous chemotherapy, had no obvious effect on vaginal radiation-induced injury (all P> 0.05) . The multifactor analysis indicated that the brachytherapy dose was an independent factor affecting the occurrence of vaginal radiation-induced injury ( P= 0.043) . Conclusion: After the radical radiotherapy of cervical cancer, the vaginal radiation-induced injury is associated with the dose of brachytherapy.
- Published
- 2018
- Full Text
- View/download PDF
44. [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China].
- Author
-
Zhang CL, Feng R, Li JT, Tian Y, Wang T, and Liu H
- Subjects
- Activities of Daily Living, Aged, Antineoplastic Combined Chemotherapy Protocols, China, Humans, Neoplasm Recurrence, Local, Treatment Outcome, Geriatric Assessment, Lymphoma, Large B-Cell, Diffuse
- Abstract
Objective: To validate comprehensive geriatric assessment (CGA) system in Chinese elderly diffuse large B cell lymphoma (DLBCL) patients. Methods: Patients ≥ 65 years of age who had been diagnosed with de novo DLBCL were screened for eligibility ( n =99). CGA was performed during staging procedures through application of the following instruments: age, comorbidity score according to the Cumulative Illness Rating Score for Geriatrics(CIRS-G), activities of daily living (ADL), and instrumental activities of daily living (IADL). Results: All patients were classified as "ft" , "unfit" , and "frail" . Forty-nine (49.5%), 14 (14.1%), and 34 (36.4%) patients were categorized into the fit, unfit, and frail groups, respectively. The overall response rate was 91.8%, 64.3%, and 69.5% in fit, unfit, and frail group, respectively ( χ (2)=9.311, P =0.007). Eleven (22.4%), 7 (50.0%), and 16(44.4%) patients showed disease relapse/progression in fit, unfit, and frail group, respectively ( χ (2)=6.309, P =0.040). The 2-year probability of overall survival was 90.6%, 43.0%, and 58.5% in fit, unfit, and frail group, respectively ( χ (2)=14.774, P =0.001). The 2-year probability of progression-free survival was 72.9%, 32.5%, and 37.3% in fit, unfit, and frail group, respectively ( χ (2)=11.038, P =0.004). Conclusion: The CGA index can predict the clinical outcomes of elderly DLBCL patients in China.
- Published
- 2018
- Full Text
- View/download PDF
45. [The study of expression and prognostic value of CD123 in acute myeloid leukemia bone marrow blasts].
- Author
-
Yue WQ, Tang GS, Liu M, Cheng H, Ding J, Wang T, Wang JM, Hu XX, Zhang WP, Chen L, and Yang JM
- Subjects
- Humans, Interleukin-3 Receptor alpha Subunit, Prognosis, Retrospective Studies, Bone Marrow, Leukemia, Myeloid, Acute
- Abstract
Objective: To study the expression of CD123 in bone marrow (BM) blasts of acute myeloid leukemia (AML) patients to explore the relationship between CD123 expression and therapeutic response and prognosis. Methods: This study retrospectively analyzed expression and distribution of CD123 in BM blasts in 137 cases of newly diagnosed AML (excluded M(3)) , CD123 detected by flow cytometry≥20% was defined as positive, including 84 CD123(+) AML and 53 CD123(-) AML, efficacy and prognosis were compared between the two groups. Results: ① Among 137 patients, 84 were in group CD123(+) (61.3%) , and 53 in group CD123(-) (38.7%) . All 137 patients were classified into risk groups based on cytogenetic and molecular biology abnormalities. No significant differences were seen between the three risk groups with regard to their CD123 levels ( χ (2)=0.861, P =0.650) . Compared with CD123(-) group, the CD123(+) group had higher WBC[47.7 (1.0-264.0) vs 22.4 (0.7-211.0) , z =-2.592, P =0.010]. ② The rates of first complete remission (CR1) and recurrence of CD123(+) group were 54.8% (46/84) and 50.8% (32/63) , respectively; and CD123(-) group were 73.6% (39/53) and 41.7% (20/48) , respectively. There was significant difference of CR1 between the two groups ( χ (2)=5.121, P =0.027) , whereas no significant difference of the recurrence rate ( χ (2)=0.911, P =0.340) . ③ The median dutations of OS between CD123(+) group and CD123(-) group were 20.0 (95% CI 13.1-26.9) months vs 44.0 (95% CI 23.6-47.3) months, respectively ( χ (2)=5.874, P =0.015) ; The median durations of DFS were 7.8 (95% CI 1.4-14.1) months vs 18.6 (95% CI 0-39.7) months, respectively, no differences were observed between the two groups ( χ (2)=2.939, P =0.086) . ④ CD123 retained an adverse prognosis value on DFS and OS within the intermediate group and patients ≤ 50 years older. Conclusions: CD123 widely expressed in AML patients, which was an independent risk factor for CR1 and OS, which implicating its important role in evaluating the induction chemotherapy response and prognosis of AML.
- Published
- 2017
- Full Text
- View/download PDF
46. [Clinical and pathological characteristics of Erdheim-Chester disease involving the lungs].
- Author
-
Lu T, Wang S, Huang H, Wang T, Wang M, Zhong DR, and Feng RE
- Subjects
- Adolescent, Adult, Biopsy, Child, Female, Humans, Lung Diseases, Interstitial, Male, Middle Aged, Tomography, X-Ray Computed, Young Adult, Erdheim-Chester Disease pathology, Lung diagnostic imaging, Lung pathology, Pleura diagnostic imaging
- Abstract
Objective: To explore the clinical manifestations, pathological features, differential diagnosis and gene mutation status in patients with pulmonary involvement of Erdheim-Chester disease (ECD). Methods: The clinical data of 4 cases of Erdheim-Chester disease admitted to Peking Union Medical College Hospital from October 2014 to August 2016 were examined for imaging, microscopic and immunohistochemitry findings, and BRAFV600E mutation. The related literatures were reviewed. Results: Among the 4 cases, there were 3 males and 1 female, aging from 7 to 47 years, and the average age was 34.5 years. They complained of chest tightness, shortness of breath and bone pain. They all had multiple bone lesions, involving the long bones, skulls and vertebrae, and imaging showed increased bone uptake and bone sclerosis. CT scan showed pleural thickening or pleural effusion(4/4), widened lobular septa(3/4), bronchial vascular bundle thickening(3/4), multiple patchy ground glass and solid shadows(4/4), and cystic shadows(1/4). Multiple bone lesions were the main extrapulmonary manifestations. All the cases had multiple bone lesions, involving the long bones, skulls and vertebrae, and showed increased bone uptake and bone sclerosis. Surgical biopsy of the thoracic tissue was performed in all 4 cases (pleural in 1 case, lung in 2, anterior mediastinal mass in 1). Microscopically, the lesion was composed of spindle-shaped fibroblasts and foamy histiocytes enmeshed in reactive fibrous tissue. Lymphocytes and plasma cells were also found. Immunohistochemically, all the histiocytes were positive for CD(68), and none of them expressed CD1a. All cases were detected by real-time quantitative PCR for BRAFV600E gene mutation. Conclusions: The pulmonary involvement of Erdheim-Chester disease is rare, with clinical manifestations of chest tightness, shortness of breath, and some have no obvious respiratory symptoms. Pulmonary involvement in Erdheim-Chester disease has important manifestations, in which foam-like tissue cells with diffuse distribution along the lymphatic enmeshed in reactive fibrous tissue. It should be differentiated from diffuse interstitial lung diseases and metastatic tumors. The clinical features are often manifested as pleural thickening and pleural effusion, with multiple bone sclerosis lesions.BRAFV600E mutation detection is helpful for the diagnosis.
- Published
- 2017
- Full Text
- View/download PDF
47. [Clinical analysis of orbital and periorbital abscess in 17 patients].
- Author
-
Zhao L, Tang LN, Wu DR, Wang T, Jian TM, and Sun FY
- Subjects
- Adult, Anti-Bacterial Agents, Drainage, Female, Humans, Male, Paranasal Sinuses, Retrospective Studies, Abscess etiology, Abscess therapy, Orbital Diseases etiology, Orbital Diseases therapy, Sinusitis etiology, Sinusitis therapy
- Abstract
Objective: To discuss the etiology, clinical features and treatment principles of the orbital and periorbital abscess. Methods: A retrospective case series of 17 cases with orbital and periorbital abscess between July 2010 and November 2015 were conducted. All patients(,) clinical data including medical history, etiology, abscess location, paranasal sinus involvement, eye involvement, microbiological test results, imaging features, treatment and prognosis were summarized and analyzed. Results: In all 17 patients, there were 10 males and 7 females with age from 3.0 to 71.0 years (the average age was 33.9 years).Eight patients(,) bacterial cultures of the pus and secretion were positive in all 17 patients. Orbital and periorbital abscess patients could manifest decreased vision, redness and swelling of eyelid, conjunctival congestion and edema, ocular motility disorders, displacement of eyeball, increased orbital pressure, abscess rupture etc. CT showed us the soft tissue mass, accompanied with sinusitis or paranasal sinus mass. MR performed with the long T(1) and T(2) signals. The signals of the abscess cavity were not uniform. For the etiology,11 cases were secondary to sinusitis, including 1 case of diabetes; 2 cases with orbital fractures.One case was secondary to orbital fracture repairment surgery. One case was secondary to the remnant of sequestrum and foreign bodys in the wound after repairment surgery. One case was injured by the hard object. One case was secondary to paranasal sinuses large B-cell lymphoma. One case had diabetic history and the blood sugar was controlled unstablly. For the treatment, 7 cases were treated by the drainage surgery which was performed via the sinus with endoscopic and abscess resection performed via the skin.Two cases were treatment by the abscess resection only.One case was treated by the drainage surgery performed via the sinus with endoscopic only. Six cases were treated by the drainage surgery performed via the skin. One case was only administered intravenous antibiotic. Sixteen cases acquired well prognosis without serious complications except 1 case which occurred central retinal artery and vein occlusion. Conclusions: The orbital and periorbital abscess is mainly a complication of paranasal sinus infection, or secondary to trauma, surgery, tumor, etc; Orbital and periorbital abscess always manifest inflammatory neoplastic clinical features, the key of the diagnosis is to make sure the etiology; Incision and drainage of the abscess is the main treatment method when necessary. We can do the surgery with other departments to avoid the occurrence of serious complications. (Chin J Ophthalmol, 2017, 53: 588-593 ) .
- Published
- 2017
- Full Text
- View/download PDF
48. [Experimental study of transforming growth factor-β3 combined with dental pulp stem cells in promoting the implant's osseointegration].
- Author
-
Wang T, Muhetaer H, and Li J
- Subjects
- Animals, Cell Differentiation, Collagen Type I analysis, Integrin-Binding Sialoprotein analysis, Osteocalcin analysis, Osteogenesis, Rabbits, Random Allocation, Stem Cells, Time Factors, Bone Substitutes administration & dosage, Dental Implants, Dental Pulp cytology, Minerals administration & dosage, Osseointegration, Stem Cell Transplantation, Transforming Growth Factor beta3 therapeutic use
- Abstract
Objective: To investigate the effect of transforming growth factor-β3 (TGF-β3) and dental pulp stem cells (DPSC) in promoting the implant's osteointegration. Methods: Thirty-three New Zealand white rabbits were randomly divided into phosphate buffer saline (PBS) group, DPSC group and TGF-β3 + DPSC group (12 rabbits/group). Two teeth from the rabbits's mandibular incisors or molars were pulled out randomly, then implant were placed in the tooth extraction site immediately. In PBS group, the implant area was filled with Bio-Oss powder 0.30 g mixed by PBS 20 μl only; while the implant area was filled with Bio-oss powder 0.30 g and 1×10(8)/L DPSC 20 μl in DPSC group; in the the TGF-β3+DPSC group the implant area was filled with Bio-Oss powder 0.30 g mixed with 1×10(8)/L DPSC 20 μl and 80 μg/L TGF-β3 20 μl. Eighteen New Zealand rabbits were executed in the 4 weeks and 8 weeks respectively. The treated alveolar bone tissue and implant were collected for plastic section. Alizarin red staining (ARS), immunohistochemical detection (IHC) of bone sialoprotein (BSP), osteocalcin (OC) and type Ⅰ collagen (COL-Ⅰ) were performed after 4 weeks and 8 weeks. Combined bone lamelta width (CBLW) and implant bone contact rate (IBCR), trabecular width (TW) and trabecular area percentage (TA) were observed by histomorphometric measurement. Results: ARS staining: 4 weeks after the operation, the TGF-β3+ DPSC group showed more red calcified nodules than the other two groups; 8 weeks after operation, the red calcified nodule was further increased. 4 weeks after the operation, the expression of BSP, OC and COL-Ⅰ was (0.35± 0.04), (0.36 ± 0.03) and (0.39 ± 0.01) respectively in TGF-β3+ DPSC group, (0.27 ± 0.02), (0.24 ± 0.01) and (0.28±0.03) respectively in DPSC group, and (0.13±0.03), (0.15±0.02) and (0.16±0.02) respectively in PBS group. Eight weeks after operation, the expression of BSP, OC and COL-Ⅰ was (0.51±0.02), (0.49±0.03) and (0.53±0.02) respectively in TGF-β3+DPSC group, (0.35±0.02), (0.37±0.01) and (0.38±0.01) respectively in DPSC group, and (0.21±0.03), (0.19±0.01) and (0.22±0.02) respectively in PBS group. After 4 weeks and 8 weeks, the expression of BSP, OC and COL-Ⅰ in TGF-β3+DPSC group were significantly higher than the other groups ( P< 0.05), there was no significant difference between DPSC group and PBS group ( P> 0.05). Eight weeks after operation, the CBLW, IBCR, TW and TA around implant in TGF-β3+ DPSC group were significantly higher than that in the other groups ( P< 0.05), there was no significant difference between DPSC group and PBS group ( P> 0.05). Conclusions: The DPSC has the potential osteogenic differentiation ability; TGF-β3 can accelerate the osteogenic differentiation of DPSC to some extent; TGF-β3 combined with DPSC can effectively promote the implant's osseointegration.
- Published
- 2017
- Full Text
- View/download PDF
49. [Effect of NCCN (2015) risk stratification on prognosis of patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
- Author
-
Lu Y, Wu T, Zhao YL, Cao XY, Liu DY, Zhang JP, Xiong M, Zhou JR, Sun RJ, Wei ZJ, Wang H, Liu HX, Wang T, Tong CR, Ji SQ, and Lu DP
- Subjects
- Chronic Disease, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Humans, Journal Impact Factor, Prognosis, Recurrence, Retrospective Studies, Risk, Tissue Donors, Transplantation, Homologous, Leukemia, Myeloid, Acute
- Abstract
Objective: To analyze the effect of NCCN (2015) risk stratification on prognosis of patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: Retrospective analysis of 258 patients with AML in CR (186 cases in CR(1), 72 cases in CR(2)) who underwent allogeneic HSCT in our hospital between April 2012 and March 2015 according to NCCN (2015) risk stratification. Of them, 63 cases were classified as low risk, 112 cases intermediate risk and 83 cases high risk. Results: ①With the median follow up of 18 (5-41) months, two-year disease free surviva (DFS) in 258 patients was 78.0% (95% CI 60.4%-96.6%) . Two-year DFS in AML after transplantation was 78.6% (95% CI 61.0%-96.2%) in low risk, 76.0% (95% CI 84.0%-93.6%) in intermediate risk and 80.3% (95% CI 62.7%-97.9%) ( P =0.886) in high risk groups respectively. ②Univariate analysis showed that DFS has no significant difference in patient age, the median disease course before HSCT, the WBC number at the beginning of the disease, blood routine and chromosomes examination before transplantation, extramedullary disease before transplantation, disease status before transplantation, conditioning regimen, donor type, donor and recipient sex, recipient blood type, transfused MNC number, transfused CD34(+) cell number and transfused CD3(+) cell number. DFS was significant lower in primary AML than that in secondary AML ( P =0.006) and also lower in MRD positive than that in MRD negative ( P =0.003) . The accumulative relapse was significant higher in CR(2) compared to that in CR(1) ( P =0.046) . Accumulative non-relapse mortality (NRM) was significanlyt higher in secondary AML compared to that in primary AML ( P =0.004) and also higher in MRD positive compared to that in MRD negative ( P =0.010) . ③Multivariate analysis showed that MRD positive was the only significant factor in DFS and NRM. Conclusion: Allo-HSCT treatment of AML CR patients could achieve a high efficacy, which is similar between CR(1) and CR(2) patients. There is no significant correlation between NCCN (2015) risk stratification and the prognosis of AML patients with allo-HSCT treatment. Pre-conditioning MRD status monitored by multiparameter flow cytometry was the only impact factor on DFS and NRM in allo-HSCT for CR-AML patients.
- Published
- 2017
- Full Text
- View/download PDF
50. [Effect of self-expanding bare metal stents of different diameters on the trachea of dogs].
- Author
-
Wang T, Zhang J, Wang J, Pei YH, Qiu XJ, and Wang YL
- Subjects
- Animals, Dogs, Metals, Random Allocation, Tracheal Diseases, Tracheal Stenosis veterinary, Granulation Tissue pathology, Self Expandable Metallic Stents veterinary, Stents, Trachea pathology, Tracheal Stenosis therapy
- Abstract
Objective: To study the effect of self-expanding bare metal stents on the trachea of dogs, and therefore to provide useful information for choice of airway stents by interventional physicians. Methods: In this experiment, 8 beagles were randomly divided into 4 groups. Four self-expanding metal stents of different diameters (16, 18, 20 and 22 mm, respectively) were placed in the trachea of these beagles for 3 months and their impacts on normal trachea were observed. Results: In the 16 mm stent group (stent-to-airway diameter ratio 103%), good epithelialization was observed and the tracheal structure had no significant damage. In the 18 mm stent group (stent-to-airway diameter ratio 116%), slight granulation tissues were observed, but the cartilage and outer membrane were normal. In the 20 mm stent group (stent-to-airway diameter ratio 129%), severe granulation tissues were observed. Cartilage was damaged but outer membrane was normal. In the 22 mm stent group (stent-to-airway diameter ratio 142%), no obvious granulation tissues were found. Cartilage was normal, but outer membrane was ruptured. Conclusion: In a certain range, tracheal granulation tissues increased as the stent diameter increased. However, if the stent diameter continued to increase, a decreasing trend of tracheal granulation was observed, but severe tracheal injury by stent expansion force would occur.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.